Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

INTRODUCTION: The efficacy and safety of the once-daily topical ophthalmic solutions, alcaftadine 0.25% and olopatadine 0.2%, in preventing ocular itching associated with allergic conjunctivitis were evaluated. METHODS: Pooled analysis was conducted of two double-masked, multicenter, active- and pla...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: McLaurin, Eugene B., Marsico, Nicholas P., Ackerman, Stacey L., Ciolino, Joseph B., Williams, Julia M., Villanueva, Linda, Hollander, David A.
Format: Artigo
Langue:Inglês
Publié: Springer Healthcare 2014
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209090/
https://ncbi.nlm.nih.gov/pubmed/25260889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-014-0155-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires